“Can DPP-4 Enhibitors and SGLT-2 Inhibitors Pleotropic Effects be Extended to Treat Diabetic Nephropathy?”, J. Medicine, vol. 24, no. 1, pp. 43–49, Mar. 2023, doi: 10.3329/jom.v24i1.64903.